Compounds > vorinostat
Page last updated: 2024-11-04

vorinostat and Inadequate Sleep

vorinostat has been researched along with Inadequate Sleep in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wong, LW1
Chong, YS1
Wong, WLE1
Sajikumar, S1

Other Studies

1 other study available for vorinostat and Inadequate Sleep

ArticleYear
Inhibition of Histone Deacetylase Reinstates Hippocampus-Dependent Long-Term Synaptic Plasticity and Associative Memory in Sleep-Deprived Mice.
    Cerebral cortex (New York, N.Y. : 1991), 2020, 06-01, Volume: 30, Issue:7

    Topics: Animals; Association; Brain-Derived Neurotrophic Factor; CREB-Binding Protein; Cyclic AMP Response E

2020